How does testosterone undecanoate bind to the androgen receptor compared to other testosterone esters?

Once esterases cleave the undecanoate chain in systemic circulation, the released free testosterone binds the cytosolic androgen receptor with native affinity — a low-nanomolar Kd identical to endogenous testosterone. Injectable testosterone esters deliver the same hormone after enzymatic cleavage at the injection site, so receptor-binding affinity is chemically equivalent; the distinction lies in the route and kinetics of delivery, not in the receptor interaction itself.

What does the undecanoate fatty-acid chain mean for how the compound behaves in the body?

The C18 undecanoate chain confers sufficient lipophilicity to package testosterone into chylomicrons within intestinal enterocytes, directing absorption through the lymphatic system rather than the portal vein. This structural feature is the sole reason oral administration is viable without hepatotoxic 17-alpha-alkylation, making the chemical lineage of testosterone undecanoate directly responsible for its oral bioavailability and its clean hepatic safety profile.

Why does dihydrotestosterone conversion matter when using testosterone undecanoate?

Because testosterone undecanoate releases unmodified testosterone, that free hormone is a fully competent substrate for 5-alpha-reductase. The resulting DHT binds the androgen receptor with three- to fivefold higher affinity than testosterone, intensifying androgenic effects in scalp, skin, and prostate tissue. Users with genetic predisposition to androgenic side effects should factor this DHT-conversion pathway into their risk assessment, as it is absent or attenuated in 19-nor compounds.

Can the Andriol Testocaps capsules be split or opened to adjust the dose?

No — Andriol Testocaps are soft-gel capsules containing an oily solution; splitting or puncturing the shell compromises the formulation and prevents proper lymphatic absorption. Dose adjustment should be achieved by varying the number of whole capsules taken per meal, not by physically altering individual capsules. Always follow prescriber guidance when titrating the dose.

Does food intake affect how well Andriol Testocaps are absorbed?

Yes, significantly. Testosterone undecanoate absorption is dependent on dietary fat: a meal containing at least 19–23 g of fat increases chylomicron formation and substantially improves lymphatic uptake. Taking Andriol Testocaps on an empty stomach or with a fat-free meal produces markedly lower and less predictable plasma testosterone levels. For consistent androgen receptor exposure, capsules should be taken with a main meal containing a normal fat content. (2) angle_used

Andriol Testocaps 40mg/tab 60 Tabletten by MSD

Lab Tested

MSD

Andriol Testocaps 40mg/tab 60 Tabletten by MSD

Name: Andriol Testocaps 40mg/tab 60 Tablets by MSD
Brand: MSD
SKU: ORA-TUND-MSD-001
Price: 50.00 EUR
Availability: InStock

Andriol Testocaps is an oral testosterone preparation delivering 40 mg of testosterone undecanoate per capsule — a long-chain fatty-acid ester engineered to bypass hepatic first-pass metabolism and engage the androgen receptor directly after lymphatic absorption. The lipophilic undecanoate side chain governs receptor-binding kinetics, positioning this compound as a structurally distinct alternative to short-ester injectable testosterones. Quality is assured through HPLC-confirmed potency analysis and GMP-compliant batch release: every pack of 60 capsules meets pharmacopoeial identity and assay specifications.

€50.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Delivers free testosterone to androgen receptors without requiring injections or hepatotoxic 17-alpha-alkylation.
Lymphatic absorption pathway preserves native AR-binding geometry of unmodified testosterone.
Enables full downstream DHT conversion via 5-alpha-reductase for complete androgenic signalling.
Convenient 40 mg dosing unit in stable soft-gel capsules allows flexible meal-based titration.
HPLC-verified potency per capsule ensures predictable receptor occupancy across each 60-capsule pack.
GMP-compliant MSD manufacturing guarantees capsule integrity and consistent fill-weight tolerances.
Oral format supports discreet, needle-free testosterone supplementation for suitable candidates.

Phase	Dosage	Note
Receptor Saturation / Initiation	80–160 mg per day (2–4 × 40 mg capsules)	Higher end used in the first 2–3 weeks to establish adequate androgen receptor occupancy; always split across two fat-containing meals to optimise lymphatic uptake.
Maintenance / Steady-State AR Engagement	40–80 mg per day (1–2 × 40 mg capsules)	Lower dose sustains receptor-level testosterone signalling once baseline levels are established; individual response guides further titration.
Taper / Pre-PCT Transition	40 mg per day (1 capsule)	Gradual dose reduction allows the androgen receptor to down-regulate progressively before initiating post-cycle therapy; short serum half-life of oral testosterone undecanoate (~3–4 hours) makes tapering practical.

Key takeaways

Understand that lymphatic absorption bypasses liver metabolism for this oral testosterone.
Expect native androgen receptor affinity once esterases release free testosterone.
Account for DHT conversion when assessing tissue-specific androgenic responses.
Always take capsules with a fat-containing meal to maximise lymphatic uptake.
Verify every batch carries HPLC-confirmed 40 mg testosterone undecanoate content.

Testosterone Undecanoate: Androgen Receptor Binding via Lymphatic Delivery

Andriol Testocaps is an oral androgen defined by its capacity to deliver testosterone undecanoate — a C18 fatty-acid ester — through the intestinal lymphatic pathway, circumventing first-pass hepatic degradation that renders most oral testosterones impractical. This mechanism determines not only its bioavailability profile but also the precise way it presents free testosterone to androgen receptors in target tissues. Compared to 17-alpha-alkylated oral androgens, testosterone undecanoate avoids structural modifications that impair receptor-binding geometry, allowing the cleaved parent hormone to bind the androgen receptor (AR) with native affinity.

How Testosterone Undecanoate Engages the Androgen Receptor

After intestinal absorption into chylomicrons, lymphatic transport delivers testosterone undecanoate to systemic circulation, where esterases cleave the undecanoate chain and release free testosterone. Free testosterone then binds the cytosolic androgen receptor with a dissociation constant (Kd) in the low nanomolar range, consistent with endogenous testosterone. The AR–testosterone complex undergoes nuclear translocation, dimerisation, and binding to androgen-response elements (AREs), initiating transcription of genes governing nitrogen retention, erythropoiesis, and skeletal muscle protein synthesis. This full agonist activity at the AR distinguishes testosterone undecanoate mechanistically from partial-agonist SARMs, which engage only a subset of AR conformations.

DHT Conversion and Tissue-Level Receptor Selectivity

Testosterone released from testosterone undecanoate is a substrate for 5-alpha-reductase, converting to dihydrotestosterone (DHT) in androgen-sensitive tissues including scalp, prostate, and skin. DHT binds the androgen receptor with approximately three- to fivefold higher affinity than testosterone itself (referenced in receptor-binding assay data published in endocrinological pharmacology literature), amplifying androgenic signalling in 5-alpha-reductase-expressing tissues. This tissue-specific amplification is a pharmacodynamic consequence of the compound's chemical lineage as unmodified testosterone — absent in 19-nor derivatives such as nandrolone, which are poor 5-alpha-reductase substrates.

Manufacturing and Quality Assurance

MSD (Merck Sharp & Dohme) subjects each Andriol Testocaps production batch to HPLC-based identity and assay testing, verifying that testosterone undecanoate content per capsule meets the declared 40 mg label within pharmacopoeial tolerance limits. Batch release additionally requires compliance with EU GMP guidelines, ensuring consistent fill weight, capsule integrity, and shelf-life stability across all 60-capsule packs.

Usage

Confirm androgen receptor engagement goals with a qualified healthcare provider before starting, and establish baseline serum testosterone via validated immunoassay or LC-MS/MS.
Take each capsule immediately after — not before — a meal containing a normal fat content (≥ 19 g fat); fat presence in the gut is required for chylomicron packaging and lymphatic transport.
Split the daily dose across at least two meals (e.g. breakfast and dinner) to maintain more consistent plasma testosterone levels throughout the day, given the short ~3–4-hour serum half-life.
Swallow each soft-gel capsule whole with a glass of water — do not chew, crush, or puncture the capsule, as the oily fill must remain intact for correct lymphatic absorption.
Store the blister packs below 25 °C away from direct light and moisture; elevated temperatures can degrade the oily solution inside the capsule and alter potency.
Monitor serum testosterone, haematocrit, and liver enzymes periodically during use; because receptor-level activity is dose-dependent, blood-work results should guide any dose adjustments rather than subjective assessment alone.

Warnings

Contraindications: Andriol Testocaps are contraindicated in individuals with confirmed or suspected androgen-dependent malignancies (prostate or breast carcinoma), hypercalcaemia associated with bony metastases, nephrotic syndrome, or documented hypersensitivity to testosterone undecanoate or any capsule excipient. Pregnancy and lactation are absolute contraindications.

Side Effects: Because testosterone undecanoate releases unmodified testosterone, androgenic effects — including acne, accelerated androgenetic alopecia, seborrhoea, and increased erythropoiesis (elevated haematocrit) — are mechanistically linked to DHT conversion in 5-alpha-reductase-expressing tissues. Oedema secondary to sodium retention, mood fluctuations, and libido changes are dose-dependent effects mediated through androgen receptor activation.

Monitoring: Serum testosterone should be measured 3–5 hours post-dose (peak window for oral testosterone undecanoate) to assess therapeutic adequacy. Haematocrit, PSA (in males over 40), lipid panel, and liver function tests (LFTs) are recommended at baseline and at 3-month intervals during sustained use. Blood pressure monitoring is advisable given the compound's erythropoietic activity.

PCT: The short serum half-life (~3–4 hours) of oral testosterone undecanoate means endogenous HPG-axis suppression can begin to lift relatively quickly after cessation compared to long-ester injectables. Standard PCT with a SERM (e.g. tamoxifen or clomiphene) is still recommended to restore LH and FSH pulsatility; PCT typically commences 3–5 days after the last Andriol Testocaps dose.

Frequently asked questions

How does testosterone undecanoate bind to the androgen receptor compared to other testosterone esters?: Once esterases cleave the undecanoate chain in systemic circulation, the released free testosterone binds the cytosolic androgen receptor with native affinity — a low-nanomolar Kd identical to endogenous testosterone. Injectable testosterone esters deliver the same hormone after enzymatic cleavage at the injection site, so receptor-binding affinity is chemically equivalent; the distinction lies in the route and kinetics of delivery, not in the receptor interaction itself.
What does the undecanoate fatty-acid chain mean for how the compound behaves in the body?: The C18 undecanoate chain confers sufficient lipophilicity to package testosterone into chylomicrons within intestinal enterocytes, directing absorption through the lymphatic system rather than the portal vein. This structural feature is the sole reason oral administration is viable without hepatotoxic 17-alpha-alkylation, making the chemical lineage of testosterone undecanoate directly responsible for its oral bioavailability and its clean hepatic safety profile.
Why does dihydrotestosterone conversion matter when using testosterone undecanoate?: Because testosterone undecanoate releases unmodified testosterone, that free hormone is a fully competent substrate for 5-alpha-reductase. The resulting DHT binds the androgen receptor with three- to fivefold higher affinity than testosterone, intensifying androgenic effects in scalp, skin, and prostate tissue. Users with genetic predisposition to androgenic side effects should factor this DHT-conversion pathway into their risk assessment, as it is absent or attenuated in 19-nor compounds.
Can the Andriol Testocaps capsules be split or opened to adjust the dose?: No — Andriol Testocaps are soft-gel capsules containing an oily solution; splitting or puncturing the shell compromises the formulation and prevents proper lymphatic absorption. Dose adjustment should be achieved by varying the number of whole capsules taken per meal, not by physically altering individual capsules. Always follow prescriber guidance when titrating the dose.
Does food intake affect how well Andriol Testocaps are absorbed?: Yes, significantly. Testosterone undecanoate absorption is dependent on dietary fat: a meal containing at least 19–23 g of fat increases chylomicron formation and substantially improves lymphatic uptake. Taking Andriol Testocaps on an empty stomach or with a fat-free meal produces markedly lower and less predictable plasma testosterone levels. For consistent androgen receptor exposure, capsules should be taken with a main meal containing a normal fat content. (2) angle_used

Manufacturer

MSD (Merck Sharp & Dohme) brings more than a century of pharmaceutical development experience to its Andriol Testocaps product line — a heritage rooted in the company's early contributions to steroid hormone research and its ongoing commitment to regulatory compliance across international markets. For this oral testosterone preparation, batch-level quality control centres on HPLC-based content uniformity testing: chromatographic analysis confirms that testosterone undecanoate concentration per capsule falls within the pharmacopoeially permitted assay range relative to the declared 40 mg label. Capsule integrity testing and fill-weight verification are integrated into MSD's EU GMP-aligned release protocol, ensuring that the oily formulation responsible for lymphatic absorption remains intact through to the end of shelf life.

Product details

Brand	MSD
Active ingredient	testosterone undecanoate
Also known as	Testosterone Undecanoat, Andriol, Undestor, Andriol Testocaps, MSD Testosterone Undecanoat
Strength	40 mg
Form	Tabletten
Pack size	60 pieces
Item number	ORA-TUND-MSD-001

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00

Stack it with

Pairs well with these products.

High Concentration